Thrasher; Kenneth Jeff

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thrasher; Kenneth Jeff.The latest application filed is for "1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamid- e compounds, formulations containing those compounds, and their use as aicarft inhibitors in the treatment of cancers".

Company Profile

0.15.12

Thrasher; Kenneth Jeff - Indianapolis IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamid- e compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers Grant 9,776,992 - Brooks , et al. October 3, 2	2017-10-03
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamid- E Compounds, Formulations Containing Those Compounds, And Their Use As Aicarft Inhibitors In The Treatment Of Cancers App 20170233378 - BROOKS; Harold Burns ; et al.	2017-08-17
Compounds, Methods And Formulations For The Oral Delivery Of A Glucagon-like Peptide (glp-1) Compound Or A Melanocortin-4 Receptor (mic4) Agonist Peptide App 20140031287 - Herr; Robert Jason ; et al.	2014-01-30
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide Grant 8,552,039 - Herr , et al. October 8, 2	2013-10-08
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide Grant 8,546,581 - Jungheim , et al. October 1, 2	2013-10-01
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide App 20110190205 - JUNGHEIM; Louis Nickolaus ; et al.	2011-08-04
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide Grant 7,947,841 - Jungheim , et al. May 24, 2	2011-05-24
Compounds, Methods And Formulations For The Oral Delivery Of A Glucagon-like Peptide (glp-1) Compound Or A Melanocortin-4 Receptor (mc4) Agonist Peptide App 20100120876 - HERR; Robert Jason ; et al.	2010-05-13
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide Grant 7,662,771 - Herr , et al. February 16, 2	2010-02-16
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide App 20090239798 - Jungheim; Louis Nickolaus ; et al.	2009-09-24
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide App 20080214448 - Herr; Robert Jason ; et al.	2008-09-04
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide App 20070293423 - Jungheim; Louis Nickolaus ; et al.	2007-12-20
Substituted dipeptides as growth hormone secretagogues Grant 7,125,840 - Dodge , et al. October 24, 2	2006-10-24
Compounds and pharmaceutical compositions for inhibiting MRP1 Grant 7,101,891 - Cohen , et al. September 5, 2	2006-09-05
Compounds and methods for inhibiting MRP1 Grant 7,037,921 - Bonjouklian , et al. May 2, 2	2006-05-02
Growth hormone secretagogues Grant 6,992,097 - Hauser , et al. January 31, 2	2006-01-31
Growth Hormone secretagogues App 20040122234 - Hauser, Kenneth Lee ; et al.	2004-06-24
Compounds and pharmaceutical compositions for inhibiting mrp1 App 20040116460 - Cohen, Jeffrey Daniel ; et al.	2004-06-17
Methods and compounds for inhibiting MRP1 Grant 6,743,794 - Bonjouklian , et al. June 1, 2	2004-06-01
Compounds and methods for inhibiting mrp1 App 20040097507 - Bonjouklian, Rosanne ; et al.	2004-05-20
Substituted dipeptides as growth hormone secretagogues App 20040058971 - Dodge, Jeffrey Alan ; et al.	2004-03-25
Growth hormone secretagogues Grant 6,639,076 - Hauser , et al. October 28, 2	2003-10-28
Methods and compounds for inhibiting mrp1 App 20030100576 - Bonjouklian, Rosanne ; et al.	2003-05-29
Antithrombotic diamines Grant 6,265,575 - Thrasher , et al. July 24, 2	2001-07-24
Benzothiophene compounds, intermediates, processes, compositions, and methods Grant 6,075,151 - Hauser , et al. June 13, 2	2000-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.